Last reviewed · How we verify

Diclofenac Sodium Active Topical Patch 2 — Competitive Intelligence Brief

Diclofenac Sodium Active Topical Patch 2 (Diclofenac Sodium Active Topical Patch 2) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID. Area: Pain Management.

phase 2 NSAID COX-2 Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Diclofenac Sodium Active Topical Patch 2 (Diclofenac Sodium Active Topical Patch 2) — Noven Pharmaceuticals, Inc.. Diclofenac Sodium is a non-selective COX-2 inhibitor.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Diclofenac Sodium Active Topical Patch 2 TARGET Diclofenac Sodium Active Topical Patch 2 Noven Pharmaceuticals, Inc. phase 2 NSAID COX-2
Celebrex celecoxib Pfizer Inc. (originally Searle/Pharmacia) marketed Nonsteroidal Anti-inflammatory Drug [EPC] COX-2 1998-12-31
Cytotec Misoprostol Pfizer marketed NSAID combined with prostaglandin analog Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors 1988-01-01
Ibuprofen/acetaminophen Ibuprofen/acetaminophen Montefiore Medical Center marketed Analgesic/antipyretic combination (NSAID + non-NSAID analgesic) Cyclooxygenase (COX-1, COX-2) for ibuprofen; prostaglandin synthesis and central pain pathways for acetaminophen
Ibuprofen suppository Ibuprofen suppository Assaf-Harofeh Medical Center marketed Nonsteroidal anti-inflammatory drug (NSAID) Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2)
Naproxen Sodium Codeine Naproxen Sodium Codeine Istanbul Medeniyet University marketed NSAID + opioid combination analgesic COX-1/COX-2 enzymes; mu opioid receptor
Dexketoprofen Trometamol + Thiocolchicoside Dexketoprofen Trometamol + Thiocolchicoside Yuzuncu Yil University marketed NSAID + muscle relaxant combination COX-1/COX-2 (dexketoprofen); GABA receptors and microtubule dynamics (thiocolchicoside)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (NSAID class)

  1. Antibe Therapeutics Inc. · 3 drugs in this class
  2. Iroko Pharmaceuticals, LLC · 3 drugs in this class
  3. Organon and Co · 2 drugs in this class
  4. Apsen Farmaceutica S.A. · 2 drugs in this class
  5. Amneal Pharmaceuticals, LLC · 2 drugs in this class
  6. Behar, Caren, M.D. · 2 drugs in this class
  7. IDEA AG · 2 drugs in this class
  8. Noven Pharmaceuticals, Inc. · 2 drugs in this class
  9. HALEON · 2 drugs in this class
  10. Pfizer · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Diclofenac Sodium Active Topical Patch 2 — Competitive Intelligence Brief. https://druglandscape.com/ci/diclofenac-sodium-active-topical-patch-2. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing